Physiomics Plc (FRA:RVW1)

Market Cap	2.48M +81.4%
Revenue (ttm)	1.16M +85.8%
Net Income	-556.25K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	17,000
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0005 - 0.0130
Beta	n/a
RSI	48.15
Earnings Date	May 15, 2026

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxf...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Employees: 10
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RVW1

Financial Performance

In fiscal year 2025, Physiomics's revenue was 834,156, an increase of 46.20% compared to the previous year's 570,561. Losses were -415,254, -31.85% less than in 2024.

Financial numbers in GBP